查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405768

體外肺模型市場規模、佔有率和趨勢分析報告：2024-2030 年按類型、應用、最終用途、地區和細分市場進行的預測

In Vitro Lung Model Market Size, Share & Trends Analysis Report By Type (2D Model, 3D Model), By Application (Physiological Research, 3D Model Development), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

體外肺模型市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球體外肺模型市場規模將達到9.481億美元，2024年至2030年複合年成長率為17.4%。

推動市場成長的因素包括越來越注重創造動物實驗模型的替代品以及近年來全球呼吸系統相關疾病的增加。試管內肺模型幫助研究人員重現特定的呼吸系統疾病，並密切模仿這些疾病的細胞和分子特徵，以開發潛在的治療方案。因此，疾病建模有助於試管內肺模型的整體發展。此外，美國道協會 (HSUS) 報告稱，美國每年約有 5,000 萬隻動物被用於實驗。為了減少虐待動物，《動物福利法》(AWA) 制定了旨在減少對動物進行有害實驗的法規。

因此，近年來，世界各地對動物倫理待遇研究領域的認知和興趣已變得引人注目。這種重視促進了全球對試管內肺模型的需求增加。此外，雖然動物維護和測試費用昂貴，但體外模型具有成本效益，特別是對於化合物和化學品的高通量篩檢。這種成本效益對預算有限的研究人員和組織很有吸引力，使體外模型成為動物實驗的可靠替代方案。主要參與企業正在採取各種策略，包括合作夥伴關係、併購、協議和產品發布，以擴大其全球足跡和產品系列。例如，2023 年 6 月，AlveoliX 宣布了一種新的器官晶載系統，包含創新的 3D 結構特徵，使模仿任何器官變得更加方便。

體外肺部模型市場報告亮點

  • 由於方便、高效和全面，2D 模型類型將在 2023 年佔據市場主導地位。
  • 藥物研發和毒理學研究應用在 2023 年佔據市場主導地位，因為它們在藥物研發的早期階段發揮著至關重要的作用。
  • 從最終用途來看，製藥和生物技術公司因其在藥物開發和研究中的重要作用而在 2023 年佔據市場主導地位。
  • 由於該地區有主要企業和學術研究機構，北美將在 2023 年佔據該行業的主導地位。
  • 在這個市場上營運的主要企業不斷關注產品發布、合作夥伴關係和地理擴張，以維持其市場地位。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第 4 章 類型業務分析

  • 體外肺模型市場：產品變異分析
  • 2D模型
    • 2D 模型市場，2018-2030
  • 3D模型
    • 3D模型市場，2018-2030

第5章 應用業務分析

  • 體外肺部模型市場：應用變化分析
  • 藥物研發/毒理學研究
    • 藥物研發與毒性研究市場，2018-2030
  • 生理學調查
    • 生理研究市場，2018-2030
  • 3D模型開發
    • 3D模型開發市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第6章 最終用途業務分析

  • 體外肺部模型市場：最終用途變異分析
  • 學術研究所
    • 學術研究機構市場，2018-2030
  • 製藥和生物技術公司
    • 製藥和生物技術市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第7章 區域業務分析

  • 2023 年和 2030 年按地區分類的體外肺模型市場佔有率
  • 北美洲
    • 2018-2030年北美體外肺模型市場
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲體外肺模型市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太體外肺模型市場
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲體外肺模型市場
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東及非洲體外肺模型市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 公司分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介
    • Epithelix
    • MATTEK
    • MIMETAS
    • Lonza
    • Emulate
    • AlveoliX AG
    • InSphero
    • CN Bio Innovations Ltd
    • ATTC Global
    • TissUse GmbH
Product Code: GVR-4-68040-159-8

In Vitro Lung Model Market Growth & Trends:

The global in vitro lung model market size is expected to reach USD 948.1 million by 2030, growing at a CAGR of 17.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth include increasing emphasis on creating substitutes for animal testing models, and recent global rise in respiratory-related disorders over the past few years. In vitro lung models help researchers replicate specific respiratory diseases, closely mimicking the cellular and molecular characteristics of these disorders for the development of potential treatment options. Thus, disease modeling contributes to the overall growth of in vitro lung models. Furthermore, as per The Humane Society of the United States (HSUS) report, about 50 million animals are used in experiments each year in the U.S. To mitigate cruelty to animals, the Animal Welfare Act (AWA) has established regulations aimed at reducing harmful experiments on animals.

Thus, over the past few years, there has been a notable global awareness and concern regarding the ethical treatment of animals in the research field. This emphasis has contributed to the increased demand for in vitro lung models worldwide. Furthermore, maintaining and testing on animals is expensive, whereas the use of in vitro models can be more cost-effective, especially for high-throughput screening of compounds and chemicals. This cost-effectiveness is appealing to researchers and organizations with limited budgets, making in vitro models a dependable alternative to animal testing. Key participants are adopting various strategies including partnerships, mergers & acquisitions, agreements, and product launches, to expand their global footprints and product portfolio. For instance, in June 2023, AlveoliX introduced a new organ-on-chip system that includes innovative 3D structure features, making mimicking any organ more convenient.

In Vitro Lung Model Market Report Highlights:

  • 2D model type dominated the market in 2023 due to their convenience, efficiency, and comprehensive nature
  • The drug discovery & toxicology studies application segment dominated the market in 2023 as these models play a pivotal role in the early stages of pharmaceutical research & development
  • Based on end-use, the pharmaceutical & biotechnology companies segment dominated the market in 2023 due to their critical role in drug development & research
  • North America dominated the industry in 2023 owing to the presence of key players as well as academic research institutions in the region
  • Key players operating in the market constantly focus on product launches, partnerships, and geographical expansions to maintain their market position

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Application & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Application & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of respiratory diseases
      • 3.2.1.2. Advancement in cell culture technology
      • 3.2.1.3. Increasing number of research activities being done towards pulmonary drug development
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professional
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. In Vitro Lung Model Market: Product Movement Analysis
  • 4.2. 2D Model
    • 4.2.1. 2D Model Market, 2018 - 2030 (USD Million)
  • 4.3. 3D Model
    • 4.3.1. 3D Model Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. In Vitro Lung Model Market: Application Movement Analysis
  • 5.2. Drug discovery and Toxicology Studies
    • 5.2.1. Drug discovery and toxicology studies Market, 2018 - 2030 (USD Million)
  • 5.3. Physiological Research
    • 5.3.1. Physiological Research Market, 2018 - 2030 (USD Million)
  • 5.4. 3D Model Development
    • 5.4.1. 3D Model Development Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. In Vitro Lung Model Market: End-use Movement Analysis
  • 6.2. Academic Research Institutes
    • 6.2.1. Academic Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.3. Pharmaceutical and Biotechnology Companies
    • 6.3.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. In Vitro Lung Model Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Argentina In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE In Vitro Lung Model Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait In Vitro Lung Model Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Epithelix
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. MATTEK
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. MIMETAS
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Emulate
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. AlveoliX AG
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. InSphero
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. CN Bio Innovations Ltd
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. ATTC Global
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. TissUse GmbH
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 2 Global In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 3 Global In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 4 Global In Vitro Lung Model market, by region, 2018 - 2030 (USD Million)
  • TABLE 5 North America In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 6 North America In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 7 North America In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 8 North America In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 9 U.S. In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 12 Canada In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 13 Canada In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 14 Canada In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 15 Europe In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 16 Europe In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 17 Europe In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 18 Europe In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 19 UK In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 20 UK In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 21 UK In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 22 Germany In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 23 Germany In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 24 Germany In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 25 France In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 26 France In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 27 France In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Italy In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 29 Italy In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 30 Italy In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 31 Spain In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 32 Spain In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 33 Spain In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 34 Sweden In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 35 Sweden In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 36 Sweden In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 37 Norway In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 38 Norway In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 39 Norway In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 40 Denmark In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 41 Denmark In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 42 Denmark In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 Asia Pacific In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 44 Asia Pacific In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 45 Asia Pacific In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 47 Japan In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 48 Japan In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 49 Japan In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 50 China In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 51 China In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 52 China In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 53 India In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 54 India In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 55 India In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 56 Australia In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 57 Australia In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 58 Australia In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 60 South Korea In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 62 Thailand In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 63 Thailand In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 64 Thailand In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 65 Latin America In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 66 Latin America In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 67 Latin America In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 69 Brazil In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 70 Brazil In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 71 Brazil In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 72 Mexico In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 73 Mexico In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 74 Mexico In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 75 Argentina In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 76 Argentina In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 77 Argentina In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 78 MEA In Vitro Lung Model market, by country, 2018 - 2030 (USD Million)
  • TABLE 79 MEA In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 80 MEA In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 81 MEA In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 82 South Africa In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 83 South Africa In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 84 South Africa In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 85 Saudi Arabia In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 86 Saudi Arabia In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 87 Saudi Arabia In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 88 UAE In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 89 UAE In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 90 UAE In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 91 Kuwait In Vitro Lung Model market, by type, 2018 - 2030 (USD Million)
  • TABLE 92 Kuwait In Vitro Lung Model market, by application, 2018 - 2030 (USD Million)
  • TABLE 93 Kuwait In Vitro Lung Model market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 94 Key companies undertaking acquisitions
  • TABLE 95 Key companies launching new products/services
  • TABLE 96 Key companies undertaking collaborations and partnerships
  • TABLE 97 Key companies undertaking other initiatives

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 In Vitro Lung Model market segmentation
  • FIG. 8 Market snapshot, 2023
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global In Vitro Lung Model Market: Type movement analysis
  • FIG. 15 Global In Vitro Lung Model Market, for 2D Model, 2018 - 2030 (USD Million)
  • FIG. 16 Global In Vitro Lung Model Market, for 3D Model, 2018 - 2030 (USD Million)
  • FIG. 17 Global In Vitro Lung Model Market: application movement analysis
  • FIG. 18 Global In Vitro Lung Model Market, for drug discovery and toxicology studies, 2018 - 2030 (USD Million)
  • FIG. 19 Global In Vitro Lung Model Market, for 3D model development, 2018 - 2030 (USD Million)
  • FIG. 20 Global In Vitro Lung Model Market, for others, 2018 - 2030 (USD Million)
  • FIG. 21 Global In Vitro Lung Model Market: end-use movement analysis
  • FIG. 22 Global In Vitro Lung Model Market, for academic research institutes, 2018 - 2030 (USD Million)
  • FIG. 23 Global In Vitro Lung Model Market, for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 24 Global In Vitro Lung Model Market, for others, 2018 - 2030 (USD Million)
  • FIG. 25 Regional marketplace: Key takeaways
  • FIG. 26 Regional outlook, 2023 & 2030
  • FIG. 27 Global In Vitro Lung Model Market: Region movement analysis
  • FIG. 28 North America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 29 U.S. In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 30 Canada In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 31 Europe In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 32 Germany In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 33 UK In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 34 France In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 35 Italy In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 36 Spain In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 37 Denmark In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 38 Sweden In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 39 Norway In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 40 Asia Pacific In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 41 Japan In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 42 China In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 43 India In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 44 Australia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 45 South Korea In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 46 Thailand In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 47 Latin America In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 48 Brazil In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 49 Mexico In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 50 Argentina In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 51 Middle East and Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 52 South Africa In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 53 Saudi Arabia In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 54 UAE In Vitro Lung Model Market, 2018 - 2030 (USD Million)
  • FIG. 55 Kuwait In Vitro Lung Model Market, 2018 - 2030 (USD Million)